Back to search results

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

High Grade Glioma · MGMT-Unmethylated Glioblastoma · MGMT-Methylated Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Southern California, Los Angeles, California, United States

    Study coordinator · tcchen@usc.edu · (323) 409-7422
    Contact: Principal Investigator (Thomas Chen, MD)

  • University of California, San Diego, San Diego, California, United States

    Study coordinator · CancerCTO@health.ucsd.edu · 858-822-5354
    Contact: Principal Investigator (David Piccioni, MD, PhD)

  • University of California, San Francisco, California, United States

    Contact: Study coordinator (Stephanie Lewis, RN) · stephanie.lewis2@ucsf.edu · (415) 353-2193
    Contact: Study coordinator (Neuro-Oncology New Patient Coordinator) · NeuroOncNewPatientCoord@ucsf.edu
    Contact: Principal Investigator (Nicholas Butowski, MD)
    Contact: Principal Investigator (Noriyuki Kasahara, MD, PhD)

  • University of Miami, Miami, Florida, United States

    Study coordinator · xw612@med.miami.edu · (305) 243-0864
    Contact: Principal Investigator (Ashish Shah, MD)

  • Northwell Health, Lake Success, New York, United States

    Study coordinator · CI-NeuroDMT@northwell.edu · 516-941-1260
    Contact: Principal Investigator (Samuel Singer, MD)
Study leads

  • Nicholas Butowski, MD

    Principal Investigator

    University of California, San Francisco

  • Noriyuki Kasahara, MD, PhD

    Principal Investigator

    University of California, San Francisco

View source on ClinicalTrials.gov(opens in a new tab)